Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab. - Gerischer, Lea; Stascheit, Frauke; Mönch, Maximilian; Doksani, Paolo; Dusemund, Carla; Herdick, Meret; Mergenthaler, Philipp; Stein, Maike; Suboh, Amani; Schröder‐Braunstein, Jutta; Wabnitz, Guido; Lünemann, Jan D.; et al. (Annals of Clinical & Translational Neurology, 2026)